Comparative Analysis of Real-World Efficacy and Safety of Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitors in Kidney Transplant Recipients Versus Nontransplant Individuals: A Single-Center Study.
Yudai IshiyamaTakafumi YagisawaMakiko IchiokaAyumu HagiwaraTomokazu ShimizuKazuya OmotoTaiji NozakiMasashi InuiJun InoKazuhiro TakedaHiroshi TomaShoichi IidaPublished in: Transplantation proceedings (2024)
HIF-PHis demonstrate comparable efficacy for managing anemia in CKD, regardless of transplant status. However, heightened vigilance for thrombosis events is necessary during follow-up for KTRs.